For the roughly one in three people with epilepsy who rely on hormonal contraception, a quiet collision of prescriptions may be undermining their reproductive choices without their knowledge. A large study published in October 2026 found that nearly 22,000 epilepsy patients frequently received antiseizure medications that accelerate the body's breakdown of hormonal birth control, leaving many unknowingly exposed to the risk of unintended pregnancy. The stakes are heightened by the fact that unplanned pregnancy in this population carries particular dangers — from fetal complications linked to c
Study: Epilepsy drugs may undermine hormonal contraceptive effectiveness
Nearly a third of people with epilepsy on birth control take a drug that undermines it
So one in three people with epilepsy on birth control are taking a seizure drug that undermines it. That's a lot of people. Do we know if they actually got pregnant?
That's the honest limitation. The study looked at prescription records, not outcomes. They found the overlap existed, but they didn't track whether it led to contraceptive failure.
Right. And prescription records don't tell you if someone actually took the pills. So we know the risk exists in theory, but the real-world impact is still unknown.
Why does pregnancy matter so much more for people with epilepsy?
Some seizure medications are linked to birth defects. And pregnancy itself is riskier for them—higher rates of complications. An unplanned pregnancy means no time to adjust medications or start protective supplements like folic acid.
That's the human piece. It's not just about contraceptive failure in the abstract. It's about compounding medical vulnerability.
So what's the fix?
Better counseling. Not all contraceptives interact with seizure drugs. IUDs and certain implants work fine. The issue is that people aren't always told which methods are safe for them.
And that requires coordination between neurologists and gynecologists, which doesn't always happen in practice.
Is this a new problem?
The drug interactions have been known for a while. What's new is seeing the scale of it—32 percent of a large sample. That's what prompted the alarm.
Der Puls
- Nearly one in three people with epilepsy on hormonal birth control were simultaneously prescribed antiseizure drugs that can silently erode contraceptive protection — often for months at a time.
- The danger is compounded: unplanned pregnancy in epilepsy patients is not just an inconvenience but a medical emergency in waiting, with elevated risks of birth defects, developmental harm, and pregnancy complications.
- The drugs at fault — including carbamazepine, phenytoin, and topiramate — speed up the body's metabolism of hormonal contraceptives, effectively dismantling their effectiveness without any visible warning sign.
- Researchers stress that the study captures prescription overlap, not confirmed pregnancies, but the scale of the pattern — across nearly 22,000 patients — signals a systemic failure in cross-specialty coordination.
- The path forward lies not in abandoning hormonal contraception but in better counseling and a shift toward non-hormonal or long-acting options like IUDs that remain effective regardless of seizure medication.
For the roughly one in three people with epilepsy who rely on hormonal contraception, a quiet collision of prescriptions may be undermining their reproductive choices without their knowledge. A large study published in October 2026 found that nearly 22,000 epilepsy patients frequently received antiseizure medications that accelerate the body's breakdown of hormonal birth control, leaving many unknowingly exposed to the risk of unintended pregnancy. The stakes are heightened by the fact that unplanned pregnancy in this population carries particular dangers — from fetal complications linked to certain seizure drugs to elevated maternal risks — making the gap between prescription and counseling not merely a clinical oversight, but a human one.
A study published in October 2026 in the journal Neurology has exposed a troubling gap in care for people living with epilepsy: roughly one in three who use hormonal contraception are also prescribed antiseizure medications that can quietly undermine that protection. Examining records for nearly 22,000 epilepsy patients, researchers found that 32.6 percent had overlapping prescriptions for both a hormonal contraceptive and an enzyme-inducing antiseizure drug — combinations that persisted, on average, for about seven months.
The concern runs deeper than statistics. Pregnancy in people with epilepsy already carries elevated risks, and several antiseizure medications have been associated with birth defects and developmental complications in exposed fetuses. An unplanned pregnancy forecloses the chance to adjust medications in advance or begin protective folic acid supplementation — interventions that can meaningfully reduce harm. In this context, a contraceptive failure is not a minor setback but a potentially serious medical event.
Led by Laura Kirkpatrick of the University of Pittsburgh School of Medicine, the study focused on six enzyme-inducing antiseizure drugs — among them carbamazepine, phenytoin, and topiramate — which accelerate the body's metabolism of hormonal contraceptives, breaking them down faster and reducing their effectiveness. Most common hormonal methods are affected, including oral pills, patches, rings, and implants.
Kirkpatrick was careful to note that the research tracked prescriptions, not outcomes — it cannot confirm whether contraceptive failures or unintended pregnancies actually occurred. But the breadth of the overlap suggests the problem is far from rare. The researchers' call to action is practical: not to steer patients away from hormonal contraception, but to ensure they receive informed counseling. Long-acting options like intrauterine devices are unaffected by antiseizure medications and remain fully reliable. The deeper challenge is ensuring that neurology and gynecology work in concert — so that no patient is left navigating this intersection alone.
A study released in October 2026 has identified a significant gap in medical care: roughly one in three people with epilepsy who take hormonal birth control are also prescribed antiseizure medications that can render those contraceptives less reliable. The research, published in Neurology, the journal of the American Academy of Neurology, examined medical records for nearly 22,000 people with epilepsy and found that 7,154 of them—32.6 percent—had overlapping prescriptions for both a hormonal contraceptive and an enzyme-inducing antiseizure drug for at least two weeks or longer. On average, these dangerous combinations persisted for about seven months.
The concern is not abstract. People with epilepsy face elevated risks during pregnancy, including increased rates of complications for both mother and baby. Several antiseizure medications have been linked to birth defects and developmental problems in exposed fetuses. When pregnancy occurs without planning, it eliminates the opportunity to adjust medications beforehand or to begin folic acid supplementation—interventions that can reduce harm. An unintended pregnancy, in other words, compounds an already precarious medical situation.
The study, led by Laura Kirkpatrick of the University of Pittsburgh School of Medicine, looked at six enzyme-inducing antiseizure medications: carbamazepine, oxcarbazepine, phenobarbital, phenytoin, topiramate, and several others. These drugs work by speeding up the body's metabolism of hormonal contraceptives, breaking them down faster and reducing their protective effect. The contraceptive methods affected include combined oral pills, progestin-only pills, patches, vaginal rings, and subdermal implants—in other words, most of the hormonal options available to patients.
Kirkpatrick emphasized that the study did not track whether patients actually became pregnant or whether contraceptive failure occurred in practice. The research examined prescription records only, which cannot confirm whether people took their medications as directed. The findings therefore represent a potential risk rather than a documented epidemic of unintended pregnancies. Still, the sheer scale of the overlap—nearly a third of a large sample—suggests the problem is widespread enough to warrant attention.
The takeaway, according to the researchers, is not that people with epilepsy should avoid hormonal contraception. Rather, it is that informed counseling matters. Not all forms of contraception interact with antiseizure medications. Long-acting reversible methods like intrauterine devices and implants that do not rely on hormonal metabolism remain effective regardless of which seizure medications a patient takes. The challenge is ensuring that people with epilepsy know which options work for them and that prescribers coordinate across specialties—neurology and gynecology—to catch these interactions before they create risk. The study was funded by the National Institutes of Health.
Bemerkenswerte Zitate
It is important for people with epilepsy to know that not all forms of contraception are affected by these medication interactions. With informed counseling, people can choose a contraceptive method that aligns with their preferences and health needs.— Laura Kirkpatrick, MD, University of Pittsburgh School of Medicine